Issue |
Title |
File |
Vol 31, No 14 (2024) |
MicroRNA-mediated Regulation of LDL Receptor: Biological and Pharmacological Implications |
 (Eng)
|
Keshavarz R., Reiner ., Zengin G., Eid A., Sahebkar A.
|
Vol 31, No 22 (2024) |
miR-204-5p Plays a Critical Role in the Pathogenesis of Depression and Anti-depression Action of Venlafaxine in the Hippocampus of Mice |
 (Eng)
|
Guan W., Wu X., Jin X., Sheng X., Fan Y.
|
Vol 31, No 18 (2024) |
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease |
 (Eng)
|
Guan W., Chen Y., Fan Y.
|
Vol 31, No 6 (2024) |
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency |
 (Eng)
|
De S.
|
Vol 31, No 19 (2024) |
Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol |
 (Eng)
|
Zheng Y., Wang L., Wang J., Zhao T., Wang J.
|
Vol 31, No 32 (2024) |
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy |
 (Eng)
|
Vijayan Y., Sandhu J., Harikumar K.
|
Vol 31, No 20 (2024) |
Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation |
 (Eng)
|
Zhong H., Liu H., Liu H.
|
Vol 31, No 36 (2024) |
Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives |
 (Eng)
|
Tajbakhsh A., Yousefi F., Farahani N., Savardashtaki A., Reiner ., Jamialahmadi T., Sahebkar A.
|
Vol 31, No 34 (2024) |
Molecular Subtypes and Prognostic Models for Predicting Prognosis of Lung Adenocarcinoma based on MiRNA-related Genes |
 (Eng)
|
Wei Y., Zhong W., Bi Y., Liu X., Zhou Q., Liu J., Wang M., Zhang H., Chen M.
|
Vol 31, No 19 (2024) |
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile? |
 (Eng)
|
Androulakis E., Ahsan S., Papageorgiou N.
|
Vol 31, No 25 (2024) |
Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma |
 (Eng)
|
Liu J., Li H., Zhang N., Dong Q., Liang Z.
|
Vol 31, No 40 (2024) |
Multi-omics Combined with Machine Learning Facilitating the Diagnosis of Gastric Cancer |
 (Eng)
|
Li J., Xu S., Zhu F., Shen F., Zhang T., Wan X., Gong S., Liang G., Zhou Y.
|
Vol 31, No 38 (2024) |
Multi-omics Data Integration Analysis Identified Therapeutic Targets and Potential Reuse Drugs for Osteoporosis |
 (Eng)
|
Li M., Gao X., Zhang Y., Wang J., Dong R., Li P., He Y.
|
Vol 31, No 13 (2024) |
Multiple Natural Polymers in Drug and Gene Delivery Systems |
 (Eng)
|
Jiang Z., Song Z., Cao C., Yan M., Liu Z., Cheng X., Wang H., Wang Q., Liu H., Chen S.
|
Vol 31, No 22 (2024) |
Multiple Protein Biomarkers and Different Treatment Strategies for Colorectal Carcinoma: A Comprehensive Prospective |
 (Eng)
|
Chakraborty B., Agarwal S., Kori S., Das R., Kashaw V., Iyer A., Kashaw S.
|
Vol 31, No 29 (2024) |
Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery |
 (Eng)
|
de Melo Milani V., Silva M., Camargo P., de Lima Ferreira Bispo M.
|
Vol 31, No 28 (2024) |
Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy |
 (Eng)
|
Gautam R., Mittal P., Goyal R., Dua K., Mishra D., Sharma S., Singla R.
|
Vol 31, No 7 (2024) |
Natural Anticancer Agents: Their Therapeutic Potential, Challenges and Promising Outcomes |
 (Eng)
|
Tauro S., Dhokchawle B., Mohite P., Nahar D., Nadar S., Coutinho E.
|
Vol 31, No 7 (2024) |
Natural Coumarin Derivatives Targeting Melanoma |
 (Eng)
|
Silva L., Nunes J., Zhan P., Łączkowski K., Cardoso S., da Silva-Júnior E.
|
Vol 31, No 26 (2024) |
Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach |
 (Eng)
|
Fernandes D., Gomes A., da Silva C., de Medeiros Henriques I., de Menezes R., Scotti M., Teles Y., Edrada-Ebel R., de Fatima Vanderlei de Souza M.
|
Vol 31, No 31 (2024) |
Natural Plant Materials as a Source of Neuroprotective Peptides |
 (Eng)
|
Skibska A., Perlikowska R.
|
Vol 31, No 31 (2024) |
Natural Products in Liver Fibrosis Management: A Five-year Review |
 (Eng)
|
Wang T., Lu Z., Sun G., He K., Chen Z., Qu X., Han X.
|
Vol 31, No 1 (2024) |
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery |
 (Eng)
|
El-Seedi H., Ibrahim H., Yosri N., Ibrahim M., Hegazy M., Setzer W., Guo Z., Zou X., Refaey M., Salem S., Musharraf S., Saeed A., Salem S., Xu B., Zhao C., Khalifa S.
|
Vol 31, No 32 (2024) |
Natures Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization |
 (Eng)
|
Kumari R., Syeda S., Shrivastava A.
|
Vol 31, No 38 (2024) |
Neuroprotective Effect of Natural Indole and β-carboline Alkaloids against Parkinsons Disease: An Overview |
 (Eng)
|
Shome A., Chahat ., Chawla V., Chawla P.
|
Vol 31, No 23 (2024) |
Neuroprotective Properties of Antiepileptics: What are the Implications for Psychiatric Disorders? |
 (Eng)
|
Dell'Osso L., Nardi B., Massoni L., Gravina D., Benedetti F., Cremone I., Carpita B.
|
Vol 31, No 20 (2024) |
Neurosteroids and their Therapeutic Potential: Remembering the Contribution of Dr. Sabina Luchetti, Netherlands Institute for Neuroscience, Amsterdam, Netherlands |
 (Eng)
|
di Michele F.
|
Vol 31, No 11 (2024) |
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment |
 (Eng)
|
Rezaee M., Masihipour N., Milasi Y., Dehmordi R., Reiner ., Asadi S., Mohammadi F., Khalilzadeh P., Rostami M., Asemi Z., Mafi A.
|
Vol 31, No 21 (2024) |
New Molecules of Importance in the Prevention and Treatment of Acne: A Systematic Patent Review (2016-2020) |
 (Eng)
|
Calderón-Pardo D., Serafini M., Alves I., Aragón D.
|
Vol 31, No 33 (2024) |
New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease |
 (Eng)
|
De S.
|
Vol 31, No 9 (2024) |
NLS-3 (Levophacetoperane or (R,R) Phacetoperane): A Reverse Ester of Methylphenidate: A Literature Review |
 (Eng)
|
Konofal E., Lecendreux M., Bizot J., Lormier A., Figadère B.
|
Vol 31, No 29 (2024) |
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and their Pharmacological Implication: A Medicinal Chemistry-oriented Perspective Outline |
 (Eng)
|
Rana V., Ghosh S., Bhatt A., Bisht D., Joshi G., Purohit P.
|
Vol 31, No 34 (2024) |
Non-oxidative Modified Low-density Lipoproteins: The Underappreciated Risk Factors for Atherosclerosis |
 (Eng)
|
Zhao Y., Xu Q., He N., Jiang M., Chen Y., Ren Z., Tang Z., Wu C., Liu L.
|
Vol 31, No 17 (2024) |
Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein: What is More Important in Atherogenesis? |
 (Eng)
|
Orekhov A., Khotina V., Sukhorukov V., Sobenin I.
|
Vol 31, No 28 (2024) |
Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase |
 (Eng)
|
Bui K., Nguyen T., Barat S., Scholta T., Xing J., Bhuria V., Sipos B., Wilkens L., Nguyen L., Le H., Velavan T., Bozko P., Plentz R.
|
Vol 31, No 5 (2024) |
Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs |
 (Eng)
|
Kamal M., Akhtar S.
|
Vol 31, No 40 (2024) |
Novel Anti-tumor Bio-drugs and Therapeutic Strategies in Cancer Management: From Bench to Translational Research |
 (Eng)
|
Huang S.
|
Vol 31, No 5 (2024) |
Novel Computational Methods for Cancer Drug Design |
 (Eng)
|
Talluri S., Kamal M., Malla R.
|
Vol 31, No 40 (2024) |
Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase |
 (Eng)
|
Ullah A., Ullah S., Waqas M., Khan M., Rehman N., Khalid A., Jan A., Aziz S., Naeem M., Halim S., Khan A., Al-Harrasi A.
|
Vol 31, No 4 (2024) |
Novel Perspectives for the Diagnosis and Treatment of Gynecological Cancers using Dysregulation of PIWI Protein and PiRNAs as Biomarkers |
 (Eng)
|
Yousefi B., Sadoughi F., Asemi Z., Mansournia M., Hallajzadeh J.
|
Vol 31, No 34 (2024) |
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases |
 (Eng)
|
De S.
|
Vol 31, No 8 (2024) |
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases |
 (Eng)
|
De S.
|
Vol 31, No 3 (2024) |
Novel Synthesized Tyrosinase Inhibitors: A Systematic Patent Review (2012-Present) |
 (Eng)
|
Beltran E., Serafini M., Alves I., Aragón Novoa D.
|
Vol 31, No 35 (2024) |
Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective |
 (Eng)
|
Khalil A., Adam M.
|
Vol 31, No 10 (2024) |
Oxocarbon Acids and their Derivatives in Biological and Medicinal Chemistry |
 (Eng)
|
Ratto A., Honek J.
|
Vol 31, No 9 (2024) |
PAFAH1B3 Regulates Papillary Thyroid Carcinoma Cell Proliferation and Metastasis by Affecting the EMT |
 (Eng)
|
Jiang W., Quan R., Bhandari A., Hirachan S., Chen C., Lv S., Zheng C.
|
Vol 31, No 22 (2024) |
PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal |
 (Eng)
|
Romo-Perez A., Domínguez-Gómez G., Chávez-Blanco A., González-Fierro A., Correa-Basurto J., Dueñas-González A.
|
Vol 31, No 1 (2024) |
PBPK Modeling as an Alternative Method of Interspecies Extrapolation that Reduces the Use of Animals: A Systematic Review |
 (Eng)
|
Lancheros Porras K., Alves I., Novoa D.
|
Vol 31, No 11 (2024) |
Peptide Amphiphiles for Pharmaceutical Applications |
 (Eng)
|
Fuertes-Llanos M., Gómara M.J., Haro I., Sánchez-López E.
|
Vol 31, No 2 (2024) |
Peptide-based PROTACs: Current Challenges and Future Perspectives |
 (Eng)
|
Wang H., Chen M., Zhang X., Xie S., Qin J., Li J.
|
Vol 31, No 10 (2024) |
Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity |
 (Eng)
|
Shayan S., Nasrollahi E., Bahramvand Y., Zarei M., Atarodi A., Farsi Y., Tavakolizadeh M., Shirvaliloo M., Abbasifard M., Jamialahmadi T., Banach M., Sahebkar A.
|
Vol 31, No 22 (2024) |
Performance of Green Desymmetrization Methods toward Bioactive Cephalostatin Analogues |
 (Eng)
|
Nawasreh M., Tahtamouni L.
|
Vol 31, No 42 (2024) |
Perillyl Alcohol Promotes Relaxation in Human Umbilical Artery |
 (Eng)
|
de Sena Bastos C., Pereira-de-Morais L., de Alencar Silva A., de Menezes Dantas D., Batista P., Gomes M., de Araújo Delmondes G., de Menezes I., da Silva R., Barbosa R.
|
Vol 31, No 41 (2024) |
Periodontitis Continuum: Antecedents, Triggers, Mediators, and Treatment Strategies |
 (Eng)
|
Gasmi Benahmed A., Tippairote T., Gasmi A., Noor S., Avdeev O., Shanaida Y., Mojgani N., Emadali A., Dadar M., Bjørklund G.
|
Vol 31, No 8 (2024) |
Perspective and Prospects on Persistent Luminescent Nanoparticles for Biological Imaging and Tumor Therapy |
 (Eng)
|
Sun M., Chen M., Wang J.
|
Vol 31, No 3 (2024) |
Perspectives and Prospects on the Application of DNA Aptamer in SARS-CoV-2 |
 (Eng)
|
Liu Y., Hu B., Li J., Pei X., Hu X.
|
Vol 31, No 12 (2024) |
Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health |
 (Eng)
|
Bjørklund G., Semenova Y., Hangan T., Pen J., Aaseth J., Peana M.
|
Vol 31, No 22 (2024) |
Pharmacokinetics of Anti-rheumatic Drugs Methotrexate and Tofacitinib with its Metabolite M9 in Rats by UPLC-MS/MS |
 (Eng)
|
Gu E., Xue L., Zhou C., Xia Y., Dai G.
|
Vol 31, No 5 (2024) |
Pharmacophore & QSAR Guided Design, Synthesis, Pharmacokinetics and In vitro Evaluation of Curcumin Analogs for Anticancer Activity |
 (Eng)
|
Alam S., Verma S., Fatima K., Luqman S., Srivastava S., Khan F.
|
Vol 31, No 3 (2024) |
Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs |
 (Eng)
|
Tantra T., Singh Y., Patekar R., Kulkarni S., Kumar P., Thareja S.
|
Vol 31, No 32 (2024) |
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma |
 (Eng)
|
Rayginia T., Keerthana C., Shifana S., Pellissery M., Abhishek A., Anto R.
|
Vol 31, No 34 (2024) |
Phytochemicals as Substances that Affect Astrogliosis and their Implications for the Management of Neurodegenerative Diseases |
 (Eng)
|
Forouzanfar F., Pourbagher-Shahri A., Vafaee F., Sathyapalan T., Sahebkar A.
|
Vol 31, No 32 (2024) |
Phytochemicals as Therapeutic Agents against Cancer |
 (Eng)
|
Bharti A.
|
Vol 31, No 30 (2024) |
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults |
 (Eng)
|
De S.
|
Vol 31, No 39 (2024) |
PLGA Nanoparticles as New Drug Delivery Systems in Leishmaniasis Chemotherapy: A Review of Current Practices |
 (Eng)
|
Valiallahi A., Vazifeh Z., Gatabi Z., Davoudi M., Gatabi I.
|
Vol 31, No 37 (2024) |
Polyphenolic Nano-formulations: A New Avenue against Bacterial Infection |
 (Eng)
|
Farhadi F., Eghbali S., Torabi Parizi S., Jamialahmadi T., Gumpricht E., Sahebkar A.
|
Vol 31, No 42 (2024) |
Porphyrinuria in Autism Spectrum Disorder: A Review |
 (Eng)
|
Bjørklund G., Semenova Y., El-Ansary A., Al-Ayadhi L.
|
Vol 31, No 22 (2024) |
Potential Drugs in COVID-19 Management |
 (Eng)
|
Gasmi A., Noor S., Menzel A., Khanyk N., Semenova Y., Lysiuk R., Beley N., Bolibrukh L., Gasmi Benahmed A., Storchylo O., Bjørklund G.
|
Vol 31, No 19 (2024) |
Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients |
 (Eng)
|
Vigil F., Castro P., Hasparyk U., Bartolomei V., Silva A.
|
Vol 31, No 21 (2024) |
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2 |
 (Eng)
|
Prabhakar P., Batiha G.
|
Vol 31, No 26 (2024) |
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs |
 (Eng)
|
Li X., Liu H., Wang F., Yuan J., Guan W., Xu G.
|
Vol 31, No 31 (2024) |
Prediction of Human Microbe-Drug Association based on Layer Attention Graph Convolutional Network |
 (Eng)
|
Qu J., Ni J., Ni T., Bian Z., Liang J.
|
Vol 31, No 36 (2024) |
Predictive Analysis of Yi-Gai-San's Multifaceted Mechanisms for Tremor-dominant Parkinson's Disease via Network Pharmacology and Molecular Docking Validation |
 (Eng)
|
Lin C., Wu L., Tsai F.
|
Vol 31, No 1 (2024) |
Preface |
 (Eng)
|
Atta-ur-Rahman .
|
Vol 31, No 30 (2024) |
Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks |
 (Eng)
|
Hassan W., Al-kaabi M., Akram N., Kassim M., Pantazi A.
|
Vol 31, No 7 (2024) |
Prof. Dr. Ferid Murad (Nobel Laureate), a Great Friend of Bentham Science, Dies at the Age of 86 |
 (Eng)
|
|
Vol 31, No 42 (2024) |
Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer |
 (Eng)
|
Tian Y., Xie Y., Yi G., Wu F., Dang X., Bai F., Wang J., Zhang D.
|
Vol 31, No 29 (2024) |
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials |
 (Eng)
|
Heydari B., Sahebnasagh A., Omrani M.A., Azimi S., Dehghani M.H., Salehi-Abargouei A., Farman F., Saghafi F.
|
Vol 31, No 25 (2024) |
Protective Effects of Curcumin and its Analogues via the Nrf2 Pathway in Metabolic Syndrome |
 (Eng)
|
Rajabi S., Darroudi M., Naseri K., Farkhondeh T., Samarghandian S.
|
Vol 31, No 24 (2024) |
Protective Roles and Therapeutic Effects of Gallic Acid in the Treatment of Cardiovascular Diseases: Current Trends and Future Directions |
 (Eng)
|
Momeni Z., Danesh S., Ahmadpour M., Eshraghi R., Farkhondeh T., Pourhanifeh M., Samarghandian S.
|
Vol 31, No 3 (2024) |
Protein Folding and Molecular Basis of Memory: Molecular Vibrations and Quantum Entanglement as Basis of Consciousness |
 (Eng)
|
Atta-ur-Rahman .
|
Vol 31, No 6 (2024) |
Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective |
 (Eng)
|
Drenichev M., Borokh V.
|
Vol 31, No 8 (2024) |
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer |
 (Eng)
|
De S.
|
Vol 31, No 36 (2024) |
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review |
 (Eng)
|
Metwally K., Abo-Dya N.
|
Vol 31, No 40 (2024) |
Quantitative Structure-activity Relationship (QSAR) Modelling of Indomethacin Derivatives using Regression Analysis |
 (Eng)
|
Shukla N., Sharma B.
|
Vol 31, No 33 (2024) |
Radiotherapy-associated Sensorineural Hearing Loss in Pediatric Oncology Patients |
 (Eng)
|
Aslam M., Ahmad H., Malik H., Uinarni H., Karim Y., Akhmedov Y., Abdelbasset W., Awadh S., Abid M., Mustafa Y., Farhood B., Sahebkar A.
|
Vol 31, No 37 (2024) |
Recent Advancements in the Treatment of Alzheimers Disease: A Multitarget-directed Ligand Approach |
 (Eng)
|
Kumar S., Mahajan A., Ambatwar R., Khatik G.
|
Vol 31, No 4 (2024) |
Recent Advances and Techniques for Identifying Novel Antibacterial Targets |
 (Eng)
|
Qiu J., Tang Z., He Y., Nazli A.
|
Vol 31, No 26 (2024) |
Recent Advances in Protein Folding Pathway Prediction through Computational Methods |
 (Eng)
|
Zhao K., Liang F., Xia Y., Hou M., Zhang G.
|
Vol 31, No 18 (2024) |
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis |
 (Eng)
|
Liu C., Li S., Zhang C., Jin C.
|
Vol 31, No 37 (2024) |
Recent Advances in the Synthesis and Analysis of Atorvastatin and its Intermediates |
 (Eng)
|
Li S., Zhang W., Zhang W., Huang A., Zhu J., Wang Y., Zheng Y.
|
Vol 31, No 20 (2024) |
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications |
 (Eng)
|
Chen P., Lou L., Sharma B., Li M., Xie C., Yang F., Wu Y., Xiao Q., Gao L.
|
Vol 31, No 17 (2024) |
Recent Advances on the Antimicrobial Activities of Schiff Bases and their Metal Complexes: An Updated Overview |
 (Eng)
|
Jorge J., Del Pino Santos K., Timóteo F., Piva Vasconcelos R.R., Ignacio Ayala Cáceres O., Juliane Arantes Granja I., de Souza D., Allievi Frizon T.E., Di Vaccari Botteselle G., Luiz Braga A., Saba S., Rashid H., Rafique J.
|
Vol 31, No 35 (2024) |
Recent Developments in Coumarin Derivatives as Neuroprotective Agents |
 (Eng)
|
Mishra P., Kumar A., Kaur K., Jaitak V.
|
Vol 31, No 10 (2024) |
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses |
 (Eng)
|
De S.
|
Vol 31, No 30 (2024) |
Recent Update on the Protective Potentials of Resveratrol against Cisplatin-induced Ototoxicity: A Systematic Review |
 (Eng)
|
Alsaikhan F., Jasim S., Margiana R., Opulencia M.J., Yasin G., Hammid A., Nasretdinova M., Mahdi A., Farhood B., Abedi-Firouzjah R., Jamialahmadi T., Sahebkar A.
|
Vol 31, No 25 (2024) |
Recent Updates on Interaction Studies and Drug Delivery of Antimalarials with Serum Albumin Proteins |
 (Eng)
|
Azeem K., Irfan I., Rashid Q., Singh S., Patel R., Abid M.
|
Vol 31, No 23 (2024) |
Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases |
 (Eng)
|
Kumari P., Beeraka N., Tengli A., Bannimath G., Baath R., Patil M.
|
Vol 31, No 34 (2024) |
Regulatory Non-coding RNAs Involved in Oxidative Stress and Neuroinflammation: An Intriguing Crosstalk in Parkinsons Disease |
 (Eng)
|
Khish N., Ghiasizadeh P., Rasti A., Moghimi O., Zadeh A., Bahiraee A., Ebrahimi R.
|
Vol 31, No 24 (2024) |
Research Progress in Estrogen-related Receptor Gamma (ERRγ) Agonists and Inverse Agonists |
 (Eng)
|
Zheng Y., Du Y., Zhang H., Lv H., Yan Z., Dong N., Li Q., Wang T.
|
201 - 300 of 400 Items |
<< < 1 2 3 4 > >> |